Shenzhen New Industries Biomedical Engineering Co., Ltd. Share Price
Equities
300832
CNE100003T39
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 52.34 CNY | +0.17% |
|
+0.21% | -6.95% |
| Capitalization | 41.12B 5.96B 5.12B 4.65B 4.46B 8.14B 549B 8.44B 54.62B 21.87B 262B 22.37B 21.88B 936B | P/E ratio 2025 * |
24.4x | P/E ratio 2026 * | 20.4x |
|---|---|---|---|---|---|
| Enterprise value | 39.84B 5.77B 4.96B 4.5B 4.32B 7.89B 532B 8.17B 52.91B 21.19B 254B 21.67B 21.2B 906B | EV / Sales 2025 * |
8.47x | EV / Sales 2026 * | 7.11x |
| Free-Float |
38.88% | Yield 2025 * |
2.28% | Yield 2026 * | 2.68% |
| 1 day | +0.17% | ||
| 1 week | +0.21% | ||
| Current month | +0.02% | ||
| 1 month | -4.05% | ||
| 3 months | -12.49% | ||
| 6 months | -19.27% | ||
| Current year | -6.95% |
| 1 week | 50.36 |  | 53.08 |
| 1 month | 50.36 | | 54.72 |
| Current year | 50.36 | | 63.11 |
| 1 year | 49.01 | | 71.51 |
| 3 years | 49.01 | | 97.2 |
| 5 years | 31.76 | | 97.2 |
| 10 years | 19.83 | | 107.41 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wei Rao
CEO | Chief Executive Officer | 62 | 16/08/2012 |
Chen Liu Ding
DFI | Director of Finance/CFO | 51 | 16/08/2012 |
Jie Ma
HRO | Human Resources Officer | 33 | 30/04/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Wei Rao
CHM | Chairman | 62 | 16/08/2012 |
Dai Na Wang
BRD | Director/Board Member | 63 | 09/09/2018 |
Qing Wei Zhang
BRD | Director/Board Member | 51 | 31/07/2012 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.17% | +0.21% | -14.46% | -11.86% | 5.96B | |
| -2.24% | -0.52% | -16.90% | +2.87% | 13.47B | |
| -0.30% | -2.36% | +124.25% | +189.96% | 12.2B | |
| +2.48% | +8.47% | - | - | 5.61B | |
| -1.27% | +2.80% | -20.71% | +6.72% | 5.03B | |
| +0.20% | +0.32% | -29.05% | -37.85% | 4.38B | |
| +0.97% | +13.54% | +21.72% | +5.11% | 3.1B | |
| -2.13% | -5.16% | -16.83% | -45.07% | 2.86B | |
| -1.11% | +13.78% | +112.64% | -56.14% | 2.86B | |
| +3.93% | +4.67% | +30.76% | +52.75% | 1.84B | |
| Average | +0.07% | +4.24% | +21.27% | +11.83% | 5.73B | |
| Weighted average by Cap. | -0.41% | +2.92% | +26.47% | +38.24% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 4.7B 681M 586M 531M 510M 931M 62.79B 964M 6.24B 2.5B 29.94B 2.56B 2.5B 107B | 5.46B 791M 680M 617M 592M 1.08B 72.91B 1.12B 7.25B 2.9B 34.77B 2.97B 2.91B 124B |
| Net income | 1.68B 243M 209M 190M 182M 333M 22.44B 345M 2.23B 893M 10.7B 914M 894M 38.22B | 2.02B 292M 251M 228M 219M 399M 26.93B 414M 2.68B 1.07B 12.84B 1.1B 1.07B 45.87B |
| Net Debt | -1.29B -186M -160M -145M -139M -255M -17.18B -264M -1.71B -684M -8.19B -699M -684M -29.25B | -2.3B -334M -287M -260M -250M -456M -30.75B -472M -3.06B -1.22B -14.67B -1.25B -1.23B -52.38B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/03/26 | 52.34 ¥ | +0.17% | 4,678,401 |
| 03/03/26 | 52.25 ¥ | +3.36% | 7,523,137 |
| 02/03/26 | 50.55 ¥ | -3.40% | 5,225,577 |
| 27/02/26 | 52.33 ¥ | +0.83% | 3,735,406 |
| 26/02/26 | 51.90 ¥ | -0.63% | 3,168,523 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 300832 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition